All media enquiries:

Cognito Therapeutics CEO Brent Vaughan to Speak at CODE Conference 2021

September 15, 2021

Cognito Therapeutics Announces Formation of Payor Advisory Board

September 8, 2021

How to grow a novel category in digital therapeutics – Everett Crossland and Andy Molnar

August 6, 2021

Cognito Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2021

August 4, 2021

‘Light Flash’ Treatment Might Help Slow Alzheimer’s

July 27, 2021

Alzheimer’s Association Annual Meeting Starts with Plenty of Exciting Data

July 26, 2021

AAIC21: Cognito’s gamma frequency neuromodulation reduces brain atrophy in Alzheimer’s trial

July 26, 2021

Cognito Therapeutics Presents New Clinical Data Demonstrating Disease-Modifying Effects of Gamma Frequency Neuro-modulation on Cognitive Function and Brain Atrophy in Alzheimer’s Disease at AAIC 2021

July 26, 2021

Advancing Breakthrough Treatments for a Novel Class of Neurodegenerative Targets in Alzheimer’s Disease

July 22, 2021